SCHEMBL7474786

SCHEMBL7474786

CCCCCNc1nc(CC)c(-c2ccc(OC(C)C)cc2OC)nc1OC

nearest known ligand 0.63

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CRHR1 P34998 19/20 0.63
TLR8 Q9NR97 1/20 0.38
TLR7 Q9NYK1 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7606978 0.92 CRHR1 (0.59) CRHR1
SCHEMBL7482544 0.90 CRHR1 (0.52) CRHR1TLR8TLR7
SCHEMBL7476944 0.88 CRHR1 (0.60) CRHR1
SCHEMBL6202370 0.86 CRHR1 (0.51) CRHR1
SCHEMBL7477527 0.83 CRHR1 (0.48) CRHR1TLR8TLR7
SCHEMBL5414673 0.82 CRHR1 (0.86) CRHR1
SCHEMBL7472049 0.81 CRHR1 (0.56) CRHR1TLR7
SCHEMBL7475717 0.81 CRHR1 (0.60) CRHR1
SCHEMBL7474865 0.80 CRHR1 (0.57) CRHR1
SCHEMBL7479379 0.80 CRHR1 (0.57) CRHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1255740-A2 SUBSTITUTED ARYLPYRAZINES NEUROGEN CORPORATION (US) 2002-11-13 EP claimed
WO-2001060806-A2 SUBSTITUTED ARYLPYRAZINES NEUROGEN CORPORATION (US) 2001-08-23 WO claimed
EP-1255740-A2 SUBSTITUTED ARYLPYRAZINES NEUROGEN CORPORATION (US) 2002-11-13 EP disclosed
WO-2001060806-A2 SUBSTITUTED ARYLPYRAZINES NEUROGEN CORPORATION (US) 2001-08-23 WO disclosed